These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36685851)

  • 21. Identification and Validation of a Novel Prognostic Signature Based on Ferroptosis-Related Genes in Ovarian Cancer.
    Cheng Z; Chen Y; Huang H
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction and analysis of a novel ferroptosis-related gene signature predicting prognosis in lung adenocarcinoma.
    Zhou J; Wang X; Li Z; Jiang R
    FEBS Open Bio; 2021 Nov; 11(11):3005-3018. PubMed ID: 34499810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining three ferroptosis-based molecular subtypes and developing a prognostic risk model for high-grade serous ovarian cancer.
    Sun X; He W; Lin B; Huang W; Ye D
    Aging (Albany NY); 2024 May; 16(10):9106-9126. PubMed ID: 38795391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
    Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
    Front Immunol; 2022; 13():922315. PubMed ID: 35774794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
    Diao X; Guo C; Liu L; Wang G; Li S
    Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and Validation of a 6-Ferroptosis Related Gene Signature for Prognosis and Immune Landscape Prediction in Melanoma.
    Yue Z; Sun J; Shi L
    Front Genet; 2022; 13():887542. PubMed ID: 35692844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma.
    Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J
    Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer.
    Liu SJ; Yang YB; Zhou JX; Lin YJ; Pan YL; Pan JH
    Dis Markers; 2021; 2021():2385406. PubMed ID: 34868391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L; Wang L; He P
    Front Genet; 2022; 13():1064432. PubMed ID: 36568383
    [No Abstract]   [Full Text] [Related]  

  • 32. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
    Tang W; Xu F; Zhao M; Zhang S
    BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
    Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
    BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
    Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
    BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
    Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
    BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
    Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X
    Front Immunol; 2022; 13():1076045. PubMed ID: 36591279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
    Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
    BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma.
    Wang Q; Wang B; Ma X; Zhuang H; Xie Z; Tang C; Tan W; Yang L; Shang C; Chen Y
    J Hepatocell Carcinoma; 2023; 10():1-16. PubMed ID: 36647389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Ferroptosis-Related Signature Robustly Predicts Clinical Outcomes and Associates With Immune Microenvironment for Thyroid Cancer.
    Ge M; Niu J; Hu P; Tong A; Dai Y; Xu F; Li F
    Front Med (Lausanne); 2021; 8():637743. PubMed ID: 33928101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.